Abstract
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess whether convalescent plasma or hyperimmune immunoglobulin transfusion is effective and safe to prevent infection with SARS-CoV-2 and development of COVID-19; and to maintain the currency of the evidence, using a living systematic review approach.
| Original language | English |
|---|---|
| Article number | CD013802 |
| Journal | Cochrane Database of Systematic Reviews |
| Volume | 2020 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 6 Jan 2021 |
Bibliographical note
Funding Information:The research was supported by NHS Blood and Transplant and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.
Funding Information:
This review was published in collaboration with the Cochrane Editorial and Methods Department. We particularly thank?Clare Dooley (Managing Editor) for her excellent support. Thanks also to the Cochrane Editorial and Methods Department team, for their valuable comments on the review protocol and timely management of the editorial process. We thank all referees who read and commented on this protocol. We thank Robin Featherstone (Information Specialist, Cochrane Editorial and Methods Department) for commenting on the search strategy.?We thank Chantelle Garritty (Methodology Editor, Editorial and Methods Department) and Prof DM Altmann?(topic expert reviewer)?for reviewing and commenting on our planned methodology and the public health relevance. Thanks to Denise Mitchell for copy-editing the protocol. The research was supported by NHS Blood and Transplant and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The contents of this document reflects only the authors' view and the Commission is not responsible for any use that may be made of the information it contains. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 101015756.
Funding Information:
The contents of this document reflects only the authors' view and the Commission is not responsible for any use that may be made of the information it contains. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 101015756.
Publisher Copyright: Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.